What is Kymera Therapeutics's debt-to-assets?

Kymera Therapeutics (KYMR) reported debt-to-assets of 0× in Q1 2026.

How has Kymera Therapeutics's debt-to-assets changed year-over-year?

Kymera Therapeutics's debt-to-assets decreased by 48.6% year-over-year, from 0.1× to 0×.

What is the long-term trend for Kymera Therapeutics's debt-to-assets?

Over 5 years (2020 to 2025), Kymera Therapeutics's debt-to-assets has grown at a 4.7% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-assets mean?

Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.

Kymera Therapeutics KYMR Debt-to-assets

Debt-to-assets at other companies

PfizerPFE

0.3×0.0×

Johnson & JohnsonJNJ

0.3×0.0×

Regeneron PharmaceuticalsREGN

0.1×0.0×

ImmunityBio, Inc.IBRX

0.7×-0.4×

Krystal Biotech, Inc.KRYS

0×0.0×

Protagonist TherapeuticsPTGX

0×0.0×

Other financials

Income statement

See full

Revenue$34.4M+55.5%

Operating income-$84.2M-13.1%

Net income-$69.2M-5.6%

EPS (diluted)-$0.71+13.4%

Balance sheet

See full

Cash & equivalents$144.1M+60.2%

Total debt$82.2M-6.5%

Total equity$1.5B+95.8%

Total assets$1.7B+81.7%

Cash flow

See full

Operating cash flow-$88.8M-12.2%

CapEx$434.0K-7.1%

Free cash flow-$89.3M-12.1%

Valuation

See full

Market cap$7.44B+283%

Enterprise value$7.38B+280%

P/S144.5×+111×

Profitability

See full

Operating margin-697.7%+635pp

Net margin-612%+602pp

FCF margin-474%+92.4pp

Returns & leverage

See full

Return on equity-27.1%-3.7pp

Debt / equity0.1×-0.1×

Current ratio10.8×+2.3×

Where this comes from

Calculated from Kymera Therapeutics’s reported figures.

total debt/total assets=0×

Based on the most recent quarter.

The official record: Kymera Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kymera Therapeutics's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kymera Therapeutics's debt-to-assets?: Kymera Therapeutics (KYMR) reported debt-to-assets of 0× in Q1 2026.
How has Kymera Therapeutics's debt-to-assets changed year-over-year?: Kymera Therapeutics's debt-to-assets decreased by 48.6% year-over-year, from 0.1× to 0×.
What is the long-term trend for Kymera Therapeutics's debt-to-assets?: Over 5 years (2020 to 2025), Kymera Therapeutics's debt-to-assets has grown at a 4.7% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?: Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.